{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:39:31Z","timestamp":1773297571837,"version":"3.50.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1093\/humrep\/16.10.2066","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:42:32Z","timestamp":1027723352000},"page":"2066-2072","source":"Crossref","is-referenced-by-count":44,"title":["Clinical, endocrine and metabolic effects of acarbose, an \u03b1-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance"],"prefix":"10.1093","volume":"16","author":[{"given":"Lilliana","family":"Ciotta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo E.","family":"Calogero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Farina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"De Leo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"La Marca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,10]]},"reference":[{"key":"key\n\t\t\t\t20170410040017_BARBIERI-ETAL-1986","doi-asserted-by":"crossref","unstructured":"Barbieri, R.L., Makris, A., Randall, R.W. et al. (1986) Insulin stimulates androgen accumulation in incubation of ovarian stroma obtained from women with hyperandrogenism. J. Clin. Endocrinol. Metab., 62, 904\u2013910.","DOI":"10.1210\/jcem-62-5-904"},{"key":"key\n\t\t\t\t20170410040017_BJORNTORP-1997","doi-asserted-by":"crossref","unstructured":"Bjorntorp, P. (1997) Body fat distribution, insulin resistance, and metabolic diseases. Nutrition, 13, 795\u2013803.","DOI":"10.1016\/S0899-9007(97)00191-3"},{"key":"key\n\t\t\t\t20170410040017_BURGHEN-ETAL-1980","doi-asserted-by":"crossref","unstructured":"Burghen, G.A., Givens, G.R. and Kitabchi A.E. (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovary disease. J. Clin. Endocrinol. Metab., 50, 113\u2013116.","DOI":"10.1210\/jcem-50-1-113"},{"key":"key\n\t\t\t\t20170410040017_CHANG-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Chang, R.J., Nakamura, R.M., Judd, H.L. et al. (1989) Insulin resistance in nonobese patients with polycystic ovary disease. J. Clin. Endocrinol. Metab., 57, 356\u2013359.","DOI":"10.1210\/jcem-57-2-356"},{"key":"key\n\t\t\t\t20170410040017_CIAMPELLI-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Ciampelli, M., Fulghesu, A.M., Cucinelli, F. et al. (1997) Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensivity in women with polycystic ovary syndrome. Hum. Reprod., 12, 1897\u20131901.","DOI":"10.1093\/humrep\/12.9.1897"},{"key":"key\n\t\t\t\t20170410040017_CIARALDI-ETAL-1992","unstructured":"Ciaraldi, T.P., El-Roeiy, A., Madar, Z. et al. (1992) Cellular mechanism of insulin resistance in polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 75, 577\u2013583."},{"key":"key\n\t\t\t\t20170410040017_CIOTTA-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Ciotta, L., De Leo, V., Galvani, F. et al. (1999) Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia. Hum. Reprod., 14, 2951\u20132958.","DOI":"10.1093\/humrep\/14.12.2951"},{"key":"key\n\t\t\t\t20170410040017_CONIFF-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Coniff, R.F., Seaton, T.B., Shapiro, J.A. et al. (1995) Reduction of glycosylated hemoglobin and postprandial hyperglicemia by acarbose in patients with NIDDM. Diabetes Care, 18, 817\u2013820.","DOI":"10.2337\/diacare.18.6.817"},{"key":"key\n\t\t\t\t20170410040017_COOK-ETAL-1979","doi-asserted-by":"crossref","unstructured":"Cook, C.H., Centner, R.L., Michaels, S.E. (1979) An acne grading method using photographic standards. Arch. Dermatol., 115, 571\u2013575.","DOI":"10.1001\/archderm.1979.04010050005003"},{"key":"key\n\t\t\t\t20170410040017_DALE-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Dale, P.O., Tambo, T., Vaaler, S. et al. (1992) Body weight, hyperinsulinemia, and gonadotropin level in the polycystic ovary syndrome: evidence of two distinct populations. Fertil. Steril., 58, 487\u2013491.","DOI":"10.1016\/S0015-0282(16)55249-2"},{"key":"key\n\t\t\t\t20170410040017_DE-FRONZO-ETAL-1991","doi-asserted-by":"crossref","unstructured":"De Fronzo, R.A., Barzilai, N. and Simonsom, D.C. (1991) Mechanism of metformin action in obese and lean noninsulin dependent diabetic subjects. J. Clin. Endocrinol. Metab., 73, 1294\u20131301.","DOI":"10.1210\/jcem-73-6-1294"},{"key":"key\n\t\t\t\t20170410040017_DUNAIF-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Graf, M., Mandeli, J. et al. (1987) Characterization of groups of hyperandrogenic women with achantosis nigricansd, impaired glucose tolerance, and\/or hyperinsulinemia. J. Clin. Endocrinol. Metab., 65, 499\u2013507.","DOI":"10.1210\/jcem-65-3-499"},{"key":"key\n\t\t\t\t20170410040017_DUNAIF-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Segal, K.R., Futterweit, W. et al. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165\u20131174.","DOI":"10.2337\/diab.38.9.1165"},{"key":"key\n\t\t\t\t20170410040017_DUNAIF-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Xia, J., Book, C.B. et al. (1995) Excessive insulin receptor serine phosphorylation in cultured fibroblast and in skeletal muscle: a potential mechanism for insulin resistance in the polycystic ovary syndrome. J. Clin. Invest., 96, 801\u2013810.","DOI":"10.1172\/JCI118126"},{"key":"key\n\t\t\t\t20170410040017_DUNAIF-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Scott, D., Finegood, D. et al. (1996) The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 81, 3299\u20133306.","DOI":"10.1210\/jcem.81.9.8784087"},{"key":"key\n\t\t\t\t20170410040017_EHRMAN-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Ehrman, D.A., Rosenfield, R.L., Barnes, R.B. et al. (1992) Detection of functional ovarian hyperandrogenism in women with androgen excess. N. Engl. J. Med., 327, 157\u2013162.","DOI":"10.1056\/NEJM199207163270304"},{"key":"key\n\t\t\t\t20170410040017_FERRIMAN-AND-GALLWEY-1961","doi-asserted-by":"crossref","unstructured":"Ferriman, D. and Gallwey, J.D. (1961) Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab., 21, 1440\u20131447.","DOI":"10.1210\/jcem-21-11-1440"},{"key":"key\n\t\t\t\t20170410040017_FRANKS-1995","doi-asserted-by":"crossref","unstructured":"Franks, S. (1995) Polycystic ovary syndrome. N. Engl. J. Med., 333, 853\u2013861.","DOI":"10.1056\/NEJM199509283331307"},{"key":"key\n\t\t\t\t20170410040017_FULGHESU-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Fulghesu, A.N., Lanzone, A., Andreani, C.L. et al. (1995) Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease. Fertil. Steril., 64, 703\u2013708.","DOI":"10.1016\/S0015-0282(16)57842-X"},{"key":"key\n\t\t\t\t20170410040017_GEISTHOVEL-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Geisthovel, F., Frorath, B. and Brabant, G. (1996) Acarbose reduces elevated testosterone serum concentrations in hyperinsulinaemic premenopausal women: a pilot study. Hum. Reprod., 11, 2377\u20132381.","DOI":"10.1093\/oxfordjournals.humrep.a019118"},{"key":"key\n\t\t\t\t20170410040017_HOLMANG-AND-BJORNTORP-1992","doi-asserted-by":"crossref","unstructured":"Holmang, A. and Bjorntorp, P. (1992) The effects of testosterone on insulin sensitivity in male rats. Acta Physiol. Scand., 146, 505\u2013510.","DOI":"10.1111\/j.1748-1716.1992.tb09452.x"},{"key":"key\n\t\t\t\t20170410040017_HOLTE-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Holte, J., Bergh, T., Berne, C. et al. (1994) Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J. Clin. Endocrinol. Metab., 78, 1052\u20131058.","DOI":"10.1210\/jcem.78.5.8175959"},{"key":"key\n\t\t\t\t20170410040017_JAKOBOWICZ-AND-NESTLER-1997","unstructured":"Jakobowicz, D.J. and Nestler, J.E. (1997) 17-alpha-hydroxyprogesterone response to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome after dietary weight loss. J. Clin. Endocrinol. Metab., 82, 556\u2013560."},{"key":"key\n\t\t\t\t20170410040017_KAHN-ETAL-1976","doi-asserted-by":"crossref","unstructured":"Kahn, C.R., Flier, J.S., Bar, R.S. et al. (1976) The syndromes of insulin resistance and achantosis nigricans. Insulin-receptor disorder in men. N. Engl. J. Med., 294, 739\u2013745.","DOI":"10.1056\/NEJM197604012941401"},{"key":"key\n\t\t\t\t20170410040017_KOSAKA-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Kosaka, K., Kuzuya, T., Hagura, R. et al. (1996) Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabet. Med., 13, 109\u2013119.","DOI":"10.1002\/dme.1996.13.s6.109"},{"key":"key\n\t\t\t\t20170410040017_LEBOVITZ-1997","doi-asserted-by":"crossref","unstructured":"Lebovitz, H.E. (1997) alpha-Glucosidase inhibitors. Endocrinol. Metab. Clin. North Am., 26, 539\u2013551.","DOI":"10.1016\/S0889-8529(05)70266-8"},{"key":"key\n\t\t\t\t20170410040017_LEROITH-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Leroith, D., Werner, H., Beitner-Johnson, D. et al. (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev., 16, 143\u2013163.","DOI":"10.1210\/edrv-16-2-143"},{"key":"key\n\t\t\t\t20170410040017_MAHLER-AND-ADLER-1999","doi-asserted-by":"crossref","unstructured":"Mahler, R.J. and Adler, M.L. (1999) Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment. J. Clin. Endocrinol. Metab., 84, 1165\u20131171.","DOI":"10.1210\/jcem.84.4.5612"},{"key":"key\n\t\t\t\t20170410040017_MARSDEN-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Marsden, P.J., Murdoch, A. and Taylor, R. (1994) Severe impairment of insulin action in adipocytes from amenorrheic subject with polycystic ovary syndrome. Metabolism, 43, 1536\u20131542.","DOI":"10.1016\/0026-0495(94)90013-2"},{"key":"key\n\t\t\t\t20170410040017_MARTIKAINEN-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Martikainen, H., Salmela, P., Nuojua-Huttunen, S. et al. (1996) Adrenal steroidogenesis is related to insulin hyperandrogenic women. Fertil. Steril., 66, 564\u2013570.","DOI":"10.1016\/S0015-0282(16)58568-9"},{"key":"key\n\t\t\t\t20170410040017_MOGHETTI-ETAL-1996","unstructured":"Moghetti, P., Castello, R., Negri, C. et al. (1996) Insulin infusion amplifies 17-alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of, 17,20-lyase activity. J. Clin. Endocrinol. Metab., 81, 881\u2013886."},{"key":"key\n\t\t\t\t20170410040017_NATIONAL-DIABETES-DATA-GROUP-1979","doi-asserted-by":"crossref","unstructured":"National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes, 28, 1039\u20131057.","DOI":"10.2337\/diab.28.12.1039"},{"key":"key\n\t\t\t\t20170410040017_NESTLER-AND-JAKUBOWICZ-1997","unstructured":"Nestler, J.E. and Jakubowicz, D.J. (1997) Lean women with polycystic ovary syndrome respond to insulin reduction with decrease in ovarian P450c17alpha activity and serum androgens. J. Clin. Endocrinol. Metab., 82, 4075\u20134079."},{"key":"key\n\t\t\t\t20170410040017_NESTLER-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Nestler, J.E., Barlascini, C.O., Matt, D.W. et al. (1989) Suppression of serum insulin by Diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 68, 1027\u20131032.","DOI":"10.1210\/jcem-68-6-1027"},{"key":"key\n\t\t\t\t20170410040017_NESTLER-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Nestler, J.E., Power, L.P., Matt, D.W. et al. (1991) A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 72, 83\u201389.","DOI":"10.1210\/jcem-72-1-83"},{"key":"key\n\t\t\t\t20170410040017_OVESEN-ETAL-1983","unstructured":"Ovesen, P., Moller, J., Ingerslev, H.J. et al. (1983) Normal basal and insulin stimulated fuel metabolism in lean women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 77, 1636\u20131640."},{"key":"key\n\t\t\t\t20170410040017_POLDERMAN-ETAL-1994","unstructured":"Polderman, K.H., Gooren, L.J., Asscheman, H. et al. (1994) Induction of insulin resistance by androgens and estrogens. J. Clin. Endocrinol. Metab., 79, 265\u2013271."},{"key":"key\n\t\t\t\t20170410040017_PORETSKY-1991","doi-asserted-by":"crossref","unstructured":"Poretsky, L. (1991) On the paradox of insulin-induced hyperandrogenism in insulin resistant states. Endocr. Rev., 12, 3\u201313.","DOI":"10.1210\/edrv-12-1-3"},{"key":"key\n\t\t\t\t20170410040017_PRELEVIC-ETAL-1990A","doi-asserted-by":"crossref","unstructured":"Prelevic, G.M., Wurzburger, M.I. and Balint-Peric, L. (1990a) Lh pulsatility and response to a single s.c. injection of buserelin in polycystic ovary syndrome. Gynecol. Endocrinol., 4, 1\u20133.","DOI":"10.3109\/09513599009030686"},{"key":"key\n\t\t\t\t20170410040017_PRELEVIC-ETAL-1990B","doi-asserted-by":"crossref","unstructured":"Prelevic, G.M., Wurzburger, M.I., Balint-Peric, L. et al. (1990b) Inhibitory effects of sandostatin on secretion of luteinizing hormone and ovarian steroids in polycystic ovary syndrome. Lancet, 336, 900\u2013903.","DOI":"10.1016\/0140-6736(90)92270-R"},{"key":"key\n\t\t\t\t20170410040017_SHOUPE-ETAL-1983","doi-asserted-by":"crossref","unstructured":"Shoupe, D., Kumar, D.D. and Lobo, R.A. (1983) Insulin resistance in polycystic ovary syndrome. Am. J. Obstet. Gynecol., 147, 588\u2013592.","DOI":"10.1016\/0002-9378(83)90023-6"},{"key":"key\n\t\t\t\t20170410040017_TOELLER-1991","doi-asserted-by":"crossref","unstructured":"Toeller, M. (1991) Modulation of intestinal glucose absorption: postponement of glucose absorption by alpha-glucosidase inhibitors. In Mogensen, C.E. and Standl, E. (eds) Pharmacology of Diabetes. Walter de Gruyter, Berlin, New York.","DOI":"10.1515\/9783110850321-009"},{"key":"key\n\t\t\t\t20170410040017_VELAZQUEZ-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Velazquez, E.M., Mendoza, S., Hamer, T. et al. (1994) Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and sistolic blood pressure, while facilitating normal menses and pregnancy. Metabolism, 43, 647\u2013654.","DOI":"10.1016\/0026-0495(94)90209-7"},{"key":"key\n\t\t\t\t20170410040017_WAREHAM-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Wareham, N.J., Phillips, D.I., Byrne, C.D. et al. (1995) The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion (letter; comment). Diabet. Med., 12, 931.","DOI":"10.1111\/j.1464-5491.1995.tb00399.x"},{"key":"key\n\t\t\t\t20170410040017_WHITE-ETAL-1995","doi-asserted-by":"crossref","unstructured":"White, D., Leigh, A., Wilson, C. et al. (1995) Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory womrn with polycystic ovary syndrome. Clin. Endocrinol. (Oxf. ), 42, 475\u2013481.","DOI":"10.1111\/j.1365-2265.1995.tb02665.x"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T09:01:03Z","timestamp":1583312463000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/16.10.2066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2001,10]]},"published-print":{"date-parts":[[2001,10]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/16.10.2066","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}